Lassa fever: Implications of T-cell immunity for vaccine development

Journal of Biotechnology

Volumn 73, Issue 2-3, 1999, Pages 207-212

  Ter Meulen, J ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Lassa virus; T cell immunity; Vaccine development

Indexed keywords

ANTIBODIES; ASSAYS; CELLS; DISEASES; IMMUNIZATION; PHYSIOLOGICAL MODELS; PROTEINS; VIRUSES;

IMMUNOPATHOLOGY; LASSA FEVER; LASSA VIRUS PROTEINS; VACCINATION;

VACCINES;

CD4 ANTIGEN; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; VIRUS VACCINE;

AFRICA; CELLULAR IMMUNITY; CONFERENCE PAPER; HUMAN; LASSA FEVER; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VIRUS TRANSMISSION;

ANIMALS; BIOTECHNOLOGY; HUMANS; LASSA FEVER; LASSA VIRUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; T-LYMPHOCYTES; VIRAL VACCINES;

ANIMALIA; LASSA VIRUS; PRIMATES;

EID: 0344199394     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(99)00122-4     Document Type: Conference Paper

References (21)

1. Borden K.L.B., Dwyer E.J.C., Salvato M.S. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyeloctye leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72:1998;758-766.
2. Clegg J.C.S. Current progress towards vaccines for arenavirus-caused diseases. Vaccine. 10:1992;89-95.
3. Cummins D., McCormick J.B., Bennett D., Samba J.A., Farrar B., Machin S.J., Fischer-Hoch S.P. Acute sensorineural deafness in Lassa fever. J. Am. Med. Assoc. 264:1990;2093-2096.
4. + T-cell-mediated immunopathological disease. J. Virol. 71:1997;9672-9678.
5. Jahrling P.B. Protection of Lassa virus-infected Guinea pigs with Lassa-immune plasma of Guinea pig, primate, and human origin. J. Med. Virol. 12:1983;93-102.
6. Jahrling P.B., Peters C.J. Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development. Med. Microbiol. Immunol. 175:1986;165-167.
7. Jahrling P.B., Frame J.D., Rhoderick J.B., Monson M.H. Epidemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans. R. Soc. Trop. Med. Hyg. 79:1985;380-384.
8. Klenerman P., Hengartner H., Zinkernagel R.M. A non-retroviral RNA virus persists in DNA form. Nature. 390:1997;298-301.
9. + T-cell clone specific for an envelope glycoprotein of Lassa virus. J. Virol. 67:1993;3497-3506.
10. McCormick J.B., King I.J., Webb P.A., Johnson K.M., O'Sullivan R., Smith E.S., Trippel S., Tong T.C. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155:1987;445-455.
11. Monath T.P. Lassa Fever-New issues raised by field studies in West Africa. J. Infect. Dis. 155:1987;433-444.
12. Oehen S., Hengartner H., Zinkernagel R.M. Vaccination for disease. Science. 253:1991;195-198.
13. Pircher H., Moskophidis D., Rohrer U., Bürki K., Hengartner H., Zinkernagel R.M. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 346:1990;629-633.
14. Planz O., Seiler P., Hengartner H., Zinkernagel R.M. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies. Nature. 382:1996;726-729.
15. Selin L.K., Welsh R.M. Cytologically active memory CTL present in Lymphocytic Choriomeningitis Virus-immune mice after clearance of virus infection. J. Immunol. 158:1997;5366-5373.
16. Solbrig M.V., McCormick J.B. Lassa fever: central nervous system manifestations. J. Trop. Geograph. Neurol. 1:1991;23-30.
17. ter Meulen J., Lukashevich I., Sidibe K., Inapogui A., Marx M., Dörlemann A., Yansane M.L., Koulemou K., Chang-Claude J., Schmitz H. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am. J. Trop. Med. Hyg. 55:1996;661-666.
18. ter Meulen, J., Lukashevich, I.S., Conde, S., Yansané, L., Schmitz, H., 1996b. Symptomatic and asymptomatic Lassa virus infections in the Republic of Guinea: antibody response and phylogeny of infecting viruses. Oral presentation, 45th annual meeting of the American Society of Tropical Medicine and Hygiene, Baltimore, USA.
19. ter Meulen J., Koulemou K., Wittekindt T., Windisch K., Strigl S., Conde S., Schmitz H. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies with a simple recombinant immunoblot assay for field use. J. Clin. Microbiol. 36:1998;3143-3148.
20. Lassa fever in Sierra Leone. Weekly Epidem. Rec. 72:1997;157-164.
21. Zinkernagel R.M. Immunology taught by viruses. Science. 271:1996;173-178.